March 2018 AJP Editor Spotlight: Cannabidiol as an Adjunctive Therapy in Schizophrenia

American Journal of Psychiatry Deputy Editor Daniel S. Pine, M.D., discusses an article titled "Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial" by Philip McGuire, F.R.C.Psych., F.Med.Sci., and colleagues.